←
Simran Gupta163 posts
Simran Gupta avatar

Simran Gupta

@SimranGMD

Transplant/Oncology ID fellow @bwh_ID @mghbwhIDfellows @harvardmed. former @MayoAZ_IMRES. @UConnHealth alum. Dog mom & dancer. Tweets my own

◷ Joined November 2021▧ 18 Photos and videos
IDSA avatar
⟳ Simran Gupta retweeted
IDSA@IDSAInfo·22 Jul 2025

In @CIDJournal, @JessicaLittleMD and colleagues evaluate the immunologic, virologic, and clinical outcomes of dual/extended antiviral therapy in severely immunocompromised patients with protracted SARS-CoV-2 infection. academic.oup.com/cid/advance…

Simran Gupta avatar
Simran Gupta@SimranGMD·29 Jun 2025

Checkout our viewpoint! TLDR; PCT guided strategies in sepsis should focus on antibiotic discontinuation, but its real benefit may be in early application in the ED to support diagnostic reasoning, triage, and stewardship.

Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial ✅ Just Accepted 🔗 bit.ly/4khwD8C

Post attachment
Camille Nelson Kotton avatar
⟳ Simran Gupta retweeted
Camille Nelson Kotton@KottonNelson·25 Jun 2025

Excited to have the 4th international CMV consensus guidelines officially published!!

July 2025 issue of @TransplantJrnl ! This issue highlights: ◼Consensus Guidelines on CMV Management ◼Organ Transplantation in the UAE ◼Sequential NRP and Normothermic Perfusion in Liver Transplantation ◼Predicting Long-Term Over-immunosuppression bit.ly/TPAissue

Post attachment
Isaac Bogoch avatar
⟳ Simran Gupta retweeted
Isaac Bogoch@BogochIsaac·31 Mar 2025

Ontario is reporting 557 cases of measles so far in 2025. We had 64 cases for all of 2024.

Post attachment
Simran Gupta avatar
Simran Gupta@SimranGMD·17 Jan 2025

Excited to share our research on Cocci antifungal ppx in SOT! TLDR; For patients repeatedly pos for EIA-IgM-only w no seroconversion, compatible clinical illness, or rads findings, discontinuing antifungal ppx may be reasonable after 1st posttxp yr journals.lww.com/transplantj…

Michael Calderwood, MD, MPH avatar
⟳ Simran Gupta retweeted
Michael Calderwood, MD, MPH@CalderwoodMD·19 Oct 2024

Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia - Challenges the dogma. #IDWeek2024 pubmed.ncbi.nlm.nih.gov/3883…